君实生物：君适达已成功纳入《国家基本医疗保险、生育保险和工伤保险药品目录（2025 年）》乙类范围

Group 1 - The core point of the article is that Junshi Bioscience's drug, JS002 (brand name: Junshi Da), has been successfully included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025) under category B, which is expected to enhance its affordability and accessibility for patients, thereby promoting market expansion and increasing sales [1][2]. Group 2 - Investors inquired about the collaboration between Junshi Bioscience and Chongqing Bochuang Pharmaceutical regarding the sales performance of Junshi Da, noting a lack of updates over the past year [1]. - Junshi Bioscience responded positively, indicating that the inclusion in the insurance list will facilitate market promotion and boost sales scale [1].